NCT03560973 2025-03-13RAMESGruppo Oncologico Italiano di Ricerca ClinicaPhase 2 Completed164 enrolled
NCT03502746 2024-05-14Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated MesotheliomaHoosier Cancer Research NetworkPhase 2 Terminated34 enrolled 11 charts